The commercial launch of the integrated products provides people with type 1 diabetes a new level of flexibility and personalization in their diabetes management. Pairing twiist™ with Senseonics’ ...

With Q3 behind us, let’s have a look at ResMed (NYSE:RMD) and its peers. Patient monitoring companies within the healthcare ...

Broad availability of the twiist and Eversense 365 integrated product is expected by March 2026, as per the company.

Remote monitoring is increasing as new reimbursement paths open up. But even the best programs are no guarantee of success.

Senseonics shares gain after Eversense 365 became the first one-year implantable CGM integrated with an automated insulin ...

While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...

Last year, I used a continuous glucose monitor (CGM) for the first time, and it completely changed how I eat. After a couple of weeks using an over-the-counter Stelo CGM, I learned that sugary ...

Every January, gyms overflow with new members determined to finally prioritize their health. By March, the crowds thin, ...

Breakthrough AI model GluFormer predicts diabetes & cardiovascular mortality up to 12 years in advance by analyzing glucose ...

In a country where millions battle diabetes, the push for continuous glucose monitors has never been more critical. As ...

PreEvnt’s isaac system enters human clinical trials, bringing non-invasive, breath-based glucose monitoring closer to a late ...